Application number | Title of the application | Filing Date | Status |
---|
Array
(
[id] => 17554973
[patent_doc_number] => 11311630
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-26
[patent_title] => Magnetic particle conjugates, micelles, and methods of delivering agents
[patent_app_type] => utility
[patent_app_number] => 16/937014
[patent_app_country] => US
[patent_app_date] => 2020-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 49
[patent_no_of_words] => 12046
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16937014
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/937014 | Magnetic particle conjugates, micelles, and methods of delivering agents | Jul 22, 2020 | Issued |
Array
(
[id] => 16397235
[patent_doc_number] => 20200338093
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-29
[patent_title] => NUTRITIONAL SUPPLEMENTS FOR GROWTH ENHANCEMENT IN PRE-PUBERTAL ADOLESCENTS
[patent_app_type] => utility
[patent_app_number] => 16/928042
[patent_app_country] => US
[patent_app_date] => 2020-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10061
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 226
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16928042
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/928042 | Nutritional supplements for growth enhancement in pre-pubertal adolescents | Jul 13, 2020 | Issued |
Array
(
[id] => 16569094
[patent_doc_number] => 20210008100
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => POLYESTER BIOMATERIALS HAVING ANTIBACTERIAL AND IMMUNOREGULATORY ACTIVITIES
[patent_app_type] => utility
[patent_app_number] => 16/927576
[patent_app_country] => US
[patent_app_date] => 2020-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18202
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16927576
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/927576 | Biomaterial comprising poly(itaconate-co-citrate-co-octanediol) | Jul 12, 2020 | Issued |
Array
(
[id] => 17625510
[patent_doc_number] => 20220160525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => DRUG-ELUTING STENT
[patent_app_type] => utility
[patent_app_number] => 17/597449
[patent_app_country] => US
[patent_app_date] => 2020-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7226
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17597449
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/597449 | Drug-eluting stent including crystalline cilostazol | Jul 7, 2020 | Issued |
Array
(
[id] => 16388765
[patent_doc_number] => 20200329706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => METHODS OF USE AND PROCESSES FOR PREPARING ALCOHOLIC SOLUTIONS OF POLYVINYLPYRROLIDINE POLYMERS
[patent_app_type] => utility
[patent_app_number] => 16/922240
[patent_app_country] => US
[patent_app_date] => 2020-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2930
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16922240
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/922240 | Methods of use and processes for preparing alcoholic solutions of polyvinylpyridine polymers | Jul 6, 2020 | Issued |
Array
(
[id] => 18133929
[patent_doc_number] => 11559578
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-24
[patent_title] => Biodegradable cationic polycarbonates as adjuvants for vaccines
[patent_app_type] => utility
[patent_app_number] => 16/916860
[patent_app_country] => US
[patent_app_date] => 2020-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 35
[patent_no_of_words] => 8014
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16916860
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/916860 | Biodegradable cationic polycarbonates as adjuvants for vaccines | Jun 29, 2020 | Issued |
Array
(
[id] => 17266346
[patent_doc_number] => 11191750
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-07
[patent_title] => Use of mTOR inhibitors for treatment of familial adenomatous polyposis
[patent_app_type] => utility
[patent_app_number] => 16/915506
[patent_app_country] => US
[patent_app_date] => 2020-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 15016
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16915506
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/915506 | Use of mTOR inhibitors for treatment of familial adenomatous polyposis | Jun 28, 2020 | Issued |
Array
(
[id] => 16375174
[patent_doc_number] => 20200324016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-15
[patent_title] => POLYMER PARTICLES
[patent_app_type] => utility
[patent_app_number] => 16/913864
[patent_app_country] => US
[patent_app_date] => 2020-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10500
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16913864
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/913864 | Methods of treatment comprising administering polymer particles configured for intravascular delivery of pharmaceutical agents | Jun 25, 2020 | Issued |
Array
(
[id] => 18215168
[patent_doc_number] => 11590080
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-28
[patent_title] => Drug-loaded biodegradable microbead compositions including drug-containing vesicular agents
[patent_app_type] => utility
[patent_app_number] => 16/913314
[patent_app_country] => US
[patent_app_date] => 2020-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 19798
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16913314
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/913314 | Drug-loaded biodegradable microbead compositions including drug-containing vesicular agents | Jun 25, 2020 | Issued |
Array
(
[id] => 16482555
[patent_doc_number] => 20200376155
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => DEVICE FOR ADSORBING ODOURS
[patent_app_type] => utility
[patent_app_number] => 16/909053
[patent_app_country] => US
[patent_app_date] => 2020-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6890
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16909053
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/909053 | Device for adsorbing odours | Jun 22, 2020 | Issued |
Array
(
[id] => 16640771
[patent_doc_number] => 10918592
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-16
[patent_title] => Injectable aqueous implant formulation containing ascorbic acid
[patent_app_type] => utility
[patent_app_number] => 16/899997
[patent_app_country] => US
[patent_app_date] => 2020-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 11717
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16899997
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/899997 | Injectable aqueous implant formulation containing ascorbic acid | Jun 11, 2020 | Issued |
Array
(
[id] => 16548601
[patent_doc_number] => 10881740
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-01-05
[patent_title] => Passivated magnetic nanoparticles for cell targeting and methods of preparation and use
[patent_app_type] => utility
[patent_app_number] => 16/897074
[patent_app_country] => US
[patent_app_date] => 2020-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 10
[patent_no_of_words] => 10646
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16897074
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/897074 | Passivated magnetic nanoparticles for cell targeting and methods of preparation and use | Jun 8, 2020 | Issued |
Array
(
[id] => 18050648
[patent_doc_number] => 11524014
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-13
[patent_title] => Pharmaceutical formulations and systems for delivery of an androgenic agent and an aromatase inhibitor with sustained multi-phasic release profiles and methods of use
[patent_app_type] => utility
[patent_app_number] => 17/437525
[patent_app_country] => US
[patent_app_date] => 2020-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 27
[patent_no_of_words] => 30282
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17437525
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/437525 | Pharmaceutical formulations and systems for delivery of an androgenic agent and an aromatase inhibitor with sustained multi-phasic release profiles and methods of use | Jun 2, 2020 | Issued |
Array
(
[id] => 16482289
[patent_doc_number] => 20200375889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => BIOERODIBLE POLYESTER POLYMER IMPLANTS AND RELATED METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/888384
[patent_app_country] => US
[patent_app_date] => 2020-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5262
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16888384
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/888384 | Bioerodible polyester polymer axitinib ocular implants and related methods of use | May 28, 2020 | Issued |
Array
(
[id] => 17799082
[patent_doc_number] => 11413349
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-16
[patent_title] => Green methodology to create polymeric nanocarriers containing hydrophilic low molecular-weight drugs and providing a very high drug loading and a very high prolonged release
[patent_app_type] => utility
[patent_app_number] => 16/888438
[patent_app_country] => US
[patent_app_date] => 2020-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 30
[patent_no_of_words] => 7084
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16888438
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/888438 | Green methodology to create polymeric nanocarriers containing hydrophilic low molecular-weight drugs and providing a very high drug loading and a very high prolonged release | May 28, 2020 | Issued |
Array
(
[id] => 16511618
[patent_doc_number] => 20200390875
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => DRIED COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/881236
[patent_app_country] => US
[patent_app_date] => 2020-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11788
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16881236
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/881236 | Dried composition of saponin in a liposomal formulation with a neutral lipid, a sterol, and a cryoprotectant | May 21, 2020 | Issued |
Array
(
[id] => 17890111
[patent_doc_number] => 11453058
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-27
[patent_title] => Preparation of highly stable concentrated dispersions of silver nanoparticles using synergistic dispersing agents
[patent_app_type] => utility
[patent_app_number] => 16/879697
[patent_app_country] => US
[patent_app_date] => 2020-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 3696
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16879697
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/879697 | Preparation of highly stable concentrated dispersions of silver nanoparticles using synergistic dispersing agents | May 19, 2020 | Issued |
Array
(
[id] => 16450847
[patent_doc_number] => 20200360273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => TREATMENT OF NOCTURNAL SYMPTOMS AND MORNING AKINESIA IN SUBJECTS WITH PARKINSON'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/874274
[patent_app_country] => US
[patent_app_date] => 2020-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11994
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16874274
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/874274 | Gastroretentive treatment of nocturnal symptoms and morning akinesia in subjects with parkinson's disease | May 13, 2020 | Issued |
Array
(
[id] => 18353917
[patent_doc_number] => 11642300
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-09
[patent_title] => Method of selecting skin treatment regimens, ingredients and compositions
[patent_app_type] => utility
[patent_app_number] => 16/871670
[patent_app_country] => US
[patent_app_date] => 2020-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 7788
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16871670
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/871670 | Method of selecting skin treatment regimens, ingredients and compositions | May 10, 2020 | Issued |
Array
(
[id] => 17814239
[patent_doc_number] => 11419826
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-23
[patent_title] => Surface-modified mesoporous silica nanoparticle for blood-brain barrier penetration,tumor targeting and cancer metastasis treatment, methods of production and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/864017
[patent_app_country] => US
[patent_app_date] => 2020-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 12
[patent_no_of_words] => 10428
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16864017
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/864017 | Surface-modified mesoporous silica nanoparticle for blood-brain barrier penetration,tumor targeting and cancer metastasis treatment, methods of production and uses thereof | Apr 29, 2020 | Issued |